Renal Biomarkers for Treatment Effect of Ranibizumab for Diabetic Macular Edema

Table 3

Correlation between proteinuria status and changes in visual acuity and optical coherence tomography characteristics after month 12 after ranibizumab treatment.

	Correlation coefficient or odds ratio				value
Changes at month 12	A: normal to mildly increased proteinuria ()	B: moderately increased proteinuria ()	C: severely increased proteinuria ()	D: dialysis ()	A vs. B	A vs. C	A vs. D
LogMAR of BCVA	Reference	-0.26	-0.21	-0.21	0.053	0.063	0.28
CFT (μm)	Reference	-39	-69	-56	0.24	0.016	0.15
Intraretinal cysts	Reference	3.27	4.47	4.62	0.28	0.079	0.17
Subretinal fluid	Reference

CFT: central foveal thickness; LogMAR of BCVA: logarithm of the minimum angle of resolution of best-corrected visual acuity.